Literature DB >> 18409150

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.

C B Frederiksen1, A F Lomholt, T Lottenburger, G J Davis, B L Dowell, M A Blankenstein, I J Christensen, N Brunner, H J Nielsen.   

Abstract

BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) measurements in plasma may be useful for the early detection and prognosis of colorectal cancer (CRC). Data on analytical performance and normal intra- and interindividual biological variation are required in order to interpret the utility of TIMP-1 in CRC. The aim of this study was to establish the biological and analytical variation of plasma TIMP-1 in volunteers.
MATERIAL AND METHODS: Three separate studies were undertaken. 1: Plasma was collected from 23 volunteers 6 times within a 3-week period, first in September 2004 (round [R] 1), then repeated in May 2005 (R2) and May 2006 (R3) in the same group of individuals. TIMP-1 levels were determined by the MAC15 ELISA assay and with the Abbott ARCHITECT i2000 Immunoanalyzer. 2: Circadian variation was evaluated in plasma collected 7 times within a 24-hour period (n=16). 3: Effects of physical exercise were evaluated in plasma collected before and after bicycling (n=14). In studies 2 and 3 TIMP-1 levels were determined with the MAC15 ELISA assay only.
RESULTS: A significant correlation between TIMP-1 MAC15 and ARCHITECT i2000 was shown (rs=0.78, p<0.002), with consistently higher levels being detected by the ARCHITECT i2000. Median levels of TIMP-1 (ARCHITECT) at 8 a.m. in each round were 74.9 ng/mL (range 65.7-89.9) (R1), 87.3 ng/mL (range 72.7-127.9) (R2), and 81.9 ng/mL (range 66.8-113.6) (R3). The within-subject variation was 10.7%, the variation between rounds was 7.4%, and the intraclass correlation was 46.2%. Comparison between the 3 rounds and time of collection showed that TIMP-1 values decreased by 11% after storage for more than 16 months (p=0.0002). A systematic circadian variation in plasma TIMP-1 levels was not observed (p=0.17). No significant variation of plasma TIMP-1 was found in relation to physical exercise (p=0.92 [global test]).
CONCLUSION: Levels of plasma TIMP-1 in volunteers show limited circadian, day-to-day, week-to-week and season-to-season variation. In addition, physical exercise has no impact on plasma TIMP-1 levels. Possible storage-dependent decreases in plasma TIMP-1 levels warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409150     DOI: 10.1177/172460080802300107

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  9 in total

Review 1.  Banking of biological fluids for studies of disease-associated protein biomarkers.

Authors:  Anne-Sofie Schrohl; Sidse Würtz; Elise Kohn; Rosamonde E Banks; Hans Jørgen Nielsen; Fred C G J Sweep; Nils Brünner
Journal:  Mol Cell Proteomics       Date:  2008-08-01       Impact factor: 5.911

2.  Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.

Authors:  Bodil E Engelmann; Annika Loft; Andreas Kjær; Hans J Nielsen; Thomas A Gerds; Eric V Benzon; Nils Brünner; Ib J Christensen; Susanne H Hansson; Niels H Holländer; Michael H Kristensen; Johan Löfgren; Elena Markova; Carsten Sloth; Liselotte Højgaard
Journal:  Oncologist       Date:  2014-01-22

3.  Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.

Authors:  Tobias Täger; Clara Wiebalck; Hanna Fröhlich; Anna Corletto; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2017-08-04       Impact factor: 5.460

4.  Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.

Authors:  Niels Lech Pedersen; Mathias Mertz Petersen; Jon J Ladd; Paul D Lampe; Robert S Bresalier; Gerard J Davis; Christina Demuth; Sarah Ø Jensen; Claus L Andersen; Linnea Ferm; Ib J Christensen; Hans J Nielsen
Journal:  Clin Chim Acta       Date:  2020-04-06       Impact factor: 3.786

Review 5.  Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

Authors:  S Bünger; T Laubert; U J Roblick; J K Habermann
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-31       Impact factor: 4.553

6.  Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.

Authors:  Kinga Tóth; Árpád V Patai; Alexandra Kalmár; Barbara Kinga Barták; Zsófia Brigitta Nagy; Orsolya Galamb; Barnabás Wichmann; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2016-12-30       Impact factor: 3.201

7.  Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III.

Authors:  Irena Oblak; Franc Anderluh; Vaneja Velenik; Barbara Mozina; Janja Ocvirk; Eva Ciric; Natasa Hrovatic Podvrsnik
Journal:  Radiol Oncol       Date:  2011-08-26       Impact factor: 2.991

8.  The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer.

Authors:  Irena Oblak; Vaneja Velenik; Franc Anderluh; Barbara Mozina; Janja Ocvirk
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

9.  Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.

Authors:  Charlotte Aaberg-Jessen; Bo Halle; Stine S Jensen; Sven Müller; Unni Maria Rømer; Christian B Pedersen; Nils Brünner; Bjarne W Kristensen
Journal:  J Neurooncol       Date:  2016-09-12       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.